Mylan Inc.’s subsidiary in India, Mylan Laboratories Ltd., a manufacturer of antiretroviral (ARV) drugs, has been selected, through its South African-based subsidiary Mylan (Proprietary) Limited, as a supplier of ARV medications to the South African National Department of Health for the tender period April 1, 2015 to March 31, 2018.

As a part of this award, Mylan will supply the South African Government with triple therapy fixed dose combination (FDC) treatments. Mylan was previously selected as a supplier for the 2013/2014 tender and is continuing its support of the government’s initiative to increase the number of patients on triple therapy FDC treatment regimens in South Africa.

Mylan supplies ARV drugs to more than 100 countries around the world. In 2012, Mylan entered the South African market with a portfolio of ARV medications, consisting of first- and second-line adult and pediatric therapies, including several dual and triple FDCs.

Source: Mylan